Wayne Anderson
Chief Scientific Officer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Wayne Anderson is the Chief Scientific Officer at Neurokine Therapeutics LLC in the United States. His research focuses on protein structure, specifically in relation to the discovery of inducers of anoikis in human melanoma and investigating the implications of p38α MAPK inhibitors for neurologic and neuropsychiatric disorders. His recent publications highlight significant advancements in understanding neuroinflammation and cognitive dysfunction.
Articles (2)
Year:
2024
Year:
2020
Collaborators (5)
Karl A. Scheidt
Northwestern University
Raymond Bergan
University of Nebraska Medical Center
Amarnath Natarajan
Ruth Branham Professor of Cancer Research
University of Nebraska Medical Center
Daniel Martin Watterson
Northwestern University
Ottavio Arancio
Columbia University
Make your next move.
Prepare your application
Review drafts before you send them.